How I treat patients who are refractory to platelet transfusions
Patients with thrombocytopenia requiring ongoing platelet transfusion support may develop inadequate platelet count increments, referred to as platelet refractoriness (PR), which further complicates their care. The underlying etiologies of PR can be broadly divided into immune and nonimmune causes....
Gespeichert in:
| Veröffentlicht in: | Blood Jg. 145; H. 20; S. 2293 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
15.05.2025
|
| Schlagworte: | |
| ISSN: | 1528-0020, 1528-0020 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Patients with thrombocytopenia requiring ongoing platelet transfusion support may develop inadequate platelet count increments, referred to as platelet refractoriness (PR), which further complicates their care. The underlying etiologies of PR can be broadly divided into immune and nonimmune causes. A high index of suspicion is required to initiate testing for alloimmunization, and the leading culprit in immune PR is the development of class I HLA antibodies. The approach to diagnosis of immune PR has changed over recent years with new technologies, but questions regarding the clinical significance and interpretation of these methods have not been conclusively answered. The provision of HLA-matched platelets requires close and timely coordination between transfusion services and clinical teams; however, the true impact of their provision on clinical outcomes is not clear. This paper reviews diagnostic and management challenges, appraises the existing data available to support treatment options, and identifies research gaps. |
|---|---|
| AbstractList | Patients with thrombocytopenia requiring on-going platelet transfusion support may develop inadequate platelet count increments, referred to as Platelet Refractoriness (PR), which further complicates their care. The underlying etiologies of PR can be broadly divided into immune and non-immune causes. A high index of suspicion is required to initiate testing for alloimmunization and t leading culprit in immune PR is development of Class I Human Leukocyte Antigens (HLA) antibodies. The approach to diagnosis of immune PR has changed over the recent years with new technologies but questions regarding clinical significance and interpretation of these methods have not been conclusively answered. The provision of HLA-matched platelets requires close and timely co-ordination between transfusion services and clinical teams; however, the true impact of their provision on clinical outcomes is not clear. This paper will review diagnostic and management challenges, appraise the existing data available to support treatment options, and identify research gaps.Patients with thrombocytopenia requiring on-going platelet transfusion support may develop inadequate platelet count increments, referred to as Platelet Refractoriness (PR), which further complicates their care. The underlying etiologies of PR can be broadly divided into immune and non-immune causes. A high index of suspicion is required to initiate testing for alloimmunization and t leading culprit in immune PR is development of Class I Human Leukocyte Antigens (HLA) antibodies. The approach to diagnosis of immune PR has changed over the recent years with new technologies but questions regarding clinical significance and interpretation of these methods have not been conclusively answered. The provision of HLA-matched platelets requires close and timely co-ordination between transfusion services and clinical teams; however, the true impact of their provision on clinical outcomes is not clear. This paper will review diagnostic and management challenges, appraise the existing data available to support treatment options, and identify research gaps. Patients with thrombocytopenia requiring ongoing platelet transfusion support may develop inadequate platelet count increments, referred to as platelet refractoriness (PR), which further complicates their care. The underlying etiologies of PR can be broadly divided into immune and nonimmune causes. A high index of suspicion is required to initiate testing for alloimmunization, and the leading culprit in immune PR is the development of class I HLA antibodies. The approach to diagnosis of immune PR has changed over recent years with new technologies, but questions regarding the clinical significance and interpretation of these methods have not been conclusively answered. The provision of HLA-matched platelets requires close and timely coordination between transfusion services and clinical teams; however, the true impact of their provision on clinical outcomes is not clear. This paper reviews diagnostic and management challenges, appraises the existing data available to support treatment options, and identifies research gaps. |
| Author | Nadarajan, Veera Nahirniak, Susan Stanworth, Simon J |
| Author_xml | – sequence: 1 givenname: Susan orcidid: 0000-0002-2895-4805 surname: Nahirniak fullname: Nahirniak, Susan organization: Department of Laboratory Medicine and Pathology, Faculty of Medicine, University of Alberta, Edmonton, AB, Canada – sequence: 2 givenname: Veera surname: Nadarajan fullname: Nadarajan, Veera organization: Department of Preclinical Sciences, Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Kajang, Malaysia – sequence: 3 givenname: Simon J orcidid: 0000-0002-7414-4950 surname: Stanworth fullname: Stanworth, Simon J organization: NHS Blood and Transplant, Oxford, United Kingdom |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39970326$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNz89LwzAcBfAgE_dD754kRy-dyTdJm9yUoW4w8KLn8m33LVa6piYpY_-9Ayd4eu_w4cGbs0nve2LsVoqllBYeqs773RIEKAFgrbpgM2nAZkKAmPzrUzaP8UsIqRWYKzZVzhVCQT5jj2t_4BueAmHiA6aW-hT54dNzDMQDNQHr5MORJ8-HDhN1lE4a-9iMsfV9vGaXDXaRbs65YB8vz--rdbZ9e92snrZZrQykTGrKC-PAGecsSOMwL6qmqbWRtm5cgaiFtEILZWVl7E5XOaKRtZaVIKUrWLD7390h-O-RYir3bayp67AnP8ZSydwWubWgT_TuTMdqT7tyCO0ew7H8ew0_EXdapA |
| CitedBy_id | crossref_primary_10_1016_j_humimm_2025_111570 crossref_primary_10_36283_ziun_pjmd14_2_055 crossref_primary_10_1186_s43054_025_00407_1 |
| ContentType | Journal Article |
| Copyright | 2025 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Copyright © 2025 American Society of Hematology. |
| Copyright_xml | – notice: 2025 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. – notice: Copyright © 2025 American Society of Hematology. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1182/blood.2023022883 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Chemistry Biology Anatomy & Physiology |
| EISSN | 1528-0020 |
| ExternalDocumentID | 39970326 |
| Genre | Journal Article Review |
| GroupedDBID | --- -~X .55 0R~ 23N 2WC 34G 39C 4.4 5GY 5RE 6J9 AAEDW AALRI AAXUO ABOCM ACGFO ACVFH ADBBV ADCNI AENEX AFETI AFOSN AGCQF AITUG AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BTFSW CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EFKBS EIF EJD EX3 F5P FDB FRP GS5 GX1 H13 IH2 K-O KQ8 L7B LSO MJL N9A NPM OK1 P2P R.V RHI ROL SJN THE TR2 TWZ W2D WH7 WOQ WOW X7M YHG YKV 7X8 |
| ID | FETCH-LOGICAL-c352t-14e67592959982159a67bffc4518cf97aa4018040381b58d4b6aa51c41b0e34b2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 3 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001503924400005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1528-0020 |
| IngestDate | Sun Nov 09 11:03:56 EST 2025 Mon Jul 21 06:02:06 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 20 |
| Language | English |
| License | 2025 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c352t-14e67592959982159a67bffc4518cf97aa4018040381b58d4b6aa51c41b0e34b2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-7414-4950 0000-0002-2895-4805 |
| PMID | 39970326 |
| PQID | 3168768824 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3168768824 pubmed_primary_39970326 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-05-15 |
| PublicationDateYYYYMMDD | 2025-05-15 |
| PublicationDate_xml | – month: 05 year: 2025 text: 2025-05-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Blood |
| PublicationTitleAlternate | Blood |
| PublicationYear | 2025 |
| SSID | ssj0014325 |
| Score | 2.4967258 |
| SecondaryResourceType | review_article |
| Snippet | Patients with thrombocytopenia requiring ongoing platelet transfusion support may develop inadequate platelet count increments, referred to as platelet... Patients with thrombocytopenia requiring on-going platelet transfusion support may develop inadequate platelet count increments, referred to as Platelet... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 2293 |
| SubjectTerms | Blood Platelets - immunology Humans Platelet Count Platelet Transfusion - methods Thrombocytopenia - diagnosis Thrombocytopenia - immunology Thrombocytopenia - therapy |
| Title | How I treat patients who are refractory to platelet transfusions |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39970326 https://www.proquest.com/docview/3168768824 |
| Volume | 145 |
| WOSCitedRecordID | wos001503924400005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8NAFH6odbu4tC51YwTxFptlsp20FksFW3pQ6a3MJBMUNKlNa-m_971pQk-C4CUkkIHkzfK-t_B9AFdJzEMpzdBIlCsMLqzYEAKDFfT0MT6ImOuc7uuT3-sFg0HYLxJuedFWWZ6J-qCOs4hy5A0SWEJoHNj8dvRlkGoUVVcLCY1VqDgIZWhj-oNlFYE7WnQVXVRgEC4qy5SB3dBt4TekHU4EMEQa-BvA1I6mvfvfT9yDnQJisuZiTezDikqrUGumGF5_ztk1002fOptehY378m6rVUq_VWGzW1Tca3DXyWbskel-dFaQsOZs9pYxMVYM3etYC_bM2SRjow8ErrgO8G1Cw1NKxOUH8NJ-eG51jEJ1wYgQjE0MiysMIhA1uRiJISAIhefLJIm4awVREvpCcCL94lRilG4Qc-kJ4VoRt6SpHC7tQ1hLs1QdAws8NEcoidMv5I4npUoiW_iCcxNHmnEdLktDDvEPqVQhUpVN8-HSlHU4WszGcLSg3xgipMJjyvZO_jD6FLZtEuwlulX3DCoJ7ml1DuvR9-Q9H1_o5YLXXr_7Aym4yLM |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=How+I+treat+patients+who+are+refractory+to+platelet+transfusions&rft.jtitle=Blood&rft.au=Nahirniak%2C+Susan&rft.au=Sekaran+Nadarajan%2C+Veera&rft.au=Stanworth%2C+Simon+J&rft.date=2025-05-15&rft.issn=1528-0020&rft.eissn=1528-0020&rft_id=info:doi/10.1182%2Fblood.2023022883&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-0020&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-0020&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-0020&client=summon |